Indonesia, 15 Mar 2022 - The projection of a global transition from pandemic to endemic status has continued to accelerate the development of technology, digitalisation, and the healthcare industry as one of the industries that attract the most attention. Deloitte’s research report in 2021 [1] Rudy Tandjung, Head of Consumer Banking Group, PT Bank DBS Indonesia, said, “DBS Treasures as a trusted wealth management partner continues to enrich investment solution options that are personalised and communicated to customers. Through the Bahana Global Healthcare Sharia USD Equity that will be available effectively starting 25 March 2022, DBS Treasures opens access for customers who want to diversify their USD denominated investments, focusing on the health sector that is strengthened by the rapid growth of technological innovation. Customers can optimise their portfolios by seizing opportunities at the right time through the digital flexibility of the omni-channel approach that includes phone instructions and the digibank by DBS application that makes the Single Investor Identity (SID) registration process easy so customers can buy, sell, and switch mutual funds online, anywhere and anytime.”[2] ) to drive medical progress, and health technology.Danica Adhitama, Marketing Director, Bahana TCW, said, “In view of the changes in investment trends that are promising for investors, we collaborate with DBS Treasures to present the Bahana Global Healthcare Sharia USD Equity fund to fulfill the needs of investors who want to increase exposure in the offshore healthcare industry. Through this collaboration, Bahana TCW strives to present a more diversified investment product for domestic investors, particularly to satisfy investors’ interest in investing in global company stocks. This product is a sharia mutual fund that focuses on the US stock market that is currently concentrated in the healthcare sector. This product is also managed in accordance with the Environment, Social & [Good Corporate] Governance (ESG) principles.”[1] 2021 Global Health Care Outlook: Accelerating industry change | Deloitte China | Life Sciences & Health Care
[2] CIOInsights1Q22_ai.pdf
[END]
About DBS DBS is a leading financial services group in Asia with a presence in 18 markets. Headquartered and listed in Singapore, DBS is in the three key Asian axes of growth: Greater China, Southeast Asia and South Asia. The bank's "AA-" and "Aa1" credit ratings are among the highest in the world.
Recognised for its global leadership, DBS has been named “World’s Best Bank ” by Euromoney, “Global Bank of the Year ” by The Banker and “Best Bank in the World ” by Global Finance. The bank is at the forefront of leveraging digital technology to shape the future of banking, having been named “World’s Best Digital Bank” by Euromoney and the world’s “Most Innovative in Digital Banking ” by The Banker. In addition, DBS has been accorded the “Safest Bank in Asia ” award by Global Finance for 13 consecutive years from 2009 to 2021.
DBS provides a full range of services in consumer, SME and corporate banking. As a bank born and bred in Asia, DBS understands the intricacies of doing business in the region’s most dynamic markets. DBS is committed to building lasting relationships with customers, and positively impacting communities through supporting social enterprises, as it banks the Asian way. It has also established a SGD 50 million foundation to strengthen its corporate social responsibility efforts in Singapore and across Asia.
With its extensive network of operations in Asia and emphasis on engaging and empowering its staff, DBS presents exciting career opportunities. For more information, please visit www.dbs.com .
